Stopped: Accrual goal met
This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbiota, and their interactions. Fluid (including but not limited to, blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in, processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC) Translational Therapy Lab (TTL).
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Immune Function after HCT
Timeframe: 7 Years
Immune Function after HCT
Timeframe: 7 Years
Immune Function after HCT
Timeframe: 7 Years
Immune Function after HCT
Timeframe: 7 Years
Immune Function after Cell Therapy/Immunotherapy
Timeframe: 7 Years
Immune Function after Cell Therapy/Immunotherapy
Timeframe: 7 Years
Immune Function after Cell Therapy/Immunotherapy
Timeframe: 7 Years
Correlate Immune Parameters
Timeframe: 7 Years
Correlate microbiota changes and their interactions with the host with outcomes of HCT
Timeframe: 7 Years